A Short Review on Mucormycosis/Black fungus
Abstract
The present article provides an outline regarding the mucormycosis, an angio invasive infection and an opportunistic condition with fungal infection that mainly targets the people who are with weaker immunity unable to fight with environmental pathogens due to other health related problems and people who are on long term medication and the present paper has been covered with all the information regarding the Predisposing factors, suspected diseased conditions, Targeted organs/tissues affected, pathophysiology, clinical manifestations, complications, diagnosis, treatment options available, and preventive measures.
Keywords
Full Text:
PDFReferences
Kwon-Chung KJ. Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clinical Infectious Diseases, 2012; 54(suppl_1): S8-15.
Mohammadi R, Nazeri M, Sayedayn SM, Ehteram H. A successful treatment of rhinocerebral mucormycosis due to Rhizopus oryzae. Journal of research in medical sciences: The Official Journal of Isfahan University of Medical Sciences, 2014; 19(1): 72.
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clinical Infectious Diseases, 2005; 41(5): 634-53.
Bitar D, Van Cauteren D, Lanternier F et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis., 2009; 15: 1395–1401.
Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clinical Infectious Diseases, 2012; 54(suppl_1): S23-34.
Waldorf AR. Pulmonary defense mechanisms against opportunistic fungal pathogens. Immunol Ser., 1989; 47: 243–271
Rammaert B, Lanternier F, Poirיe S, Kania R, Lortholary O. Diabetes and mucormycosis: a complex interplay. Diabetes & metabolism, 2012; 38(3): 193-204.
Meyer BR, Wormser G, Hirschan SZ, et al. Rhinocerebral mucormycosis: premortem diagnosis and therapy. Arch. Intern. Med., 1979; 139: 557.
Gale GR, Welch AM. Studies of opportunistic fungi. I. Inhibition of Rhizopus oryzae by human serum. Am. J. Med. Sci., 1961; 241: 604–12. European Journal of Molecular
Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J. Clin. Invest., 1984; 74: 150 60.
Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann. Thorac. Surg., 1994; 57(4): 1044- 50.
Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N. Engl. J Med., 1999; 341(25): 1906- 12.
Bhansali A, Sharma A, Kashyap A, Gupta A, Dash RJ. Mucor endophthalmitis. Acta Ophthalmol Scand., 2001; 79(1): 88- 90.
Tsaousis G, Koutsouri A, Gatsiou C, Paniara O, Peppas C, Chalevelakis G. Liver and brain mucormycosis in a diabetic patient type II successfully treated with liposomal amphotericin B. Scand. J. Infect. Dis., 2000; 32(3): 335- 7.
Waldorf AR, Levitz SM, Diamond RD. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J. Infect. Dis., 1984; 150(5): 752-60.
Artis WM, Fountain JA, Delcher HK. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes, 1982; 31: 109–14.
Cohen SG, Greenberg MS. Rhinomaxillary mucormycosis in a kidney transplant patient. Oral Surg. Oral Med. Pathol., 1980; 50: 33–8.
Marchevskey AM, Bottone EJ, Geller SA. The changing spectrum of disease etiology and diagnosis of mucormycosis. Human Pathology, 1980; 11: 457.
Sugar AM. Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. Philadelphia, PA: Elsevier, 2005; 2979.
Times Now. How can you prevent mucormycosis, the latest 'fatal' fungal infection' among covid-recovered people? (May 07, 2021).[Online] Available at: https://www.timesnownews.com/health/article/how-can-you-prevent-mucormycosis-the-latest-fatal-fungal-infection-among-covid-recovered-people/754277
Refbacks
- There are currently no refbacks.
Copyright (c) 2020 Research & Reviews: Journal of Oncology and Hematology
This Journal archive has been shifted to: https://journals.stmjournals.com/archive/rrjooh/